Progyny (PGNY) EBITDA (2018 - 2026)
Progyny (PGNY) EBITDA from Sep 30, 2018 to Mar 31, 2026. The TTM Progyny (PGNY) EBITDA is $102M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Progyny (PGNY) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +32.79% |
| 3 Years TTM | +36.33% |
| 5 Years TTM | +41.25% |
Annual EBITDA change of Progyny (PGNY)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $37M | -59.15% |
| 2025 | $90M | +27.75% |
| 2024 | $71M | +9.55% |
| 2023 | $64M | +158.50% |
| 2022 | $25M | -25.86% |
| 2021 | $34M | +228.20% |
| 2020 | $10M | -13.21% |
| 2019 | $12M | -852.23% |
| 2018 | -$1.57M | -83.39% |
| 2017 | -$9.45M | N/A |
Comparison Progyny (PGNY) five years EBITDA CAGR with competitors
Progyny (PGNY) five years EBITDA CAGR is 41.25%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| CI | Cigna Group (The) | 2.56% | -93.79% |